Stereotaxis Announces That Physicians At The Hospital Da Luz In Lisbon, Portugal Have Successfully Treated The First Patients Using The Advanced Genesis Robotic Magnetic Navigation System
Stereotaxis Announces That Physicians At The Hospital Da Luz In Lisbon, Portugal Have Successfully Treated The First Patients Using The Advanced Genesis Robotic Magnetic Navigation System
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at the Hospital da Luz in Lisbon, Portugal have successfully treated the first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System.
Stereotaxis (纽交所:STXS)是一家医疗领域里在微创血管内介入手术方面的先锋和全球领导者，今天宣布，葡萄牙里斯本的Hospital da Luz的医生成功地使用先进的Genesis 机器人磁导航（RMN）系统治疗了首批患者。
"We are excited to be at the forefront of technology and patient care by introducing the new Genesis System at Hospital da Luz," said Prof. Pedro Adragão, Cardiac Electrophysiologist at Hospital da Luz. "Robotics allows us to treat patients with effective individualized therapy and the highest focus on safety. We are pleased to offer this high-level care to all our patients, including those with the most complex arrhythmia. We also are pleased to continue advancing this important technology for the benefit of patients and medical progress."
"我们很高兴能够走在科技和患者护理的前沿，通过在Hospital da Luz引入新的Genesis系统。”Hospital da Luz的心脏心电生理学家Pedro Adragão教授表示。“机器人技术让我们能够为患者提供有效的个性化治疗，并且在安全性上给予最高的关注。我们很高兴能够为所有患者提供这种高水平的护理，包括那些最复杂的心律失常患者。我们也很高兴能够继续推动这项重要科技的发展，以造福患者和医疗进步。”
